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The  administration  of  the  2,4-dinitrophenyl  (DNP)  conjugate  of  the  "non- 
immunogenic" copolymer of D-glutamic acid and D-lysine (D-GL) 1 induces a  state of 
profound DNP-specific immunological tolerance (1-6). In our original description of 
the model several years ago (1), normal or DNP-immune inbred guinea pigs treated 
with DNP-D-GL were found  to be incapable of developing anti-DNP antibody re- 
sponses following immunization with an immunogenic DNP-protein conjugate. The 
tolerant  state  was  shown  to  be  expressed  exclusively in  the  population of  DNP- 
specific antibody-forming cell precursors as evidenced by a significant diminution in the 
frequency  of  both  DNP-specific  antigen-binding  bone  marrow-derived  (B)  lym- 
phocytes and anti-DNP antibody-forming cells in guinea pigs tolerized with DNP- 
D-GL as compared to normal or immune animals (1,  2). Moreover, tolerant animals 
displayed a very marked depression both in plaque-forming cells secreting high affinity 
anti-DNP antibody and in high affinity serum anti-DNP antibody, indicating a pref- 
erential tolerization of precursor B  cells bearing high affinity receptors (2). 
Subsequent studies in inbred mice demonstrated that administration of DNP-B-GL 
induced a state of DNP-specific tolerance in such animals irrespective of their immune 
status at the time of treatment (3). Taking advantage of the relative ease with which 
DNP-D-GL can induce tolerance in an animal previously primed with an immunogenic 
DNP-carrier conjugate, we established conditions for tolerance induction in an adop- 
tive cell transfer system. Thus,  the adoptive secondary anti-DNP antibody response 
of DNP-primed spleen cells was abolished by exposure of such cells to DNP-D-GL 
either in vivo or in vitro (3). Utilizing the adoptive transfer tolerance system, evidence 
was obtained to support the hypothesis that the tolerant state induced by DNP-D-GL 
represents an irreversible inactivation of specific B lymphocytes. This conclusion was 
based  on  the  following experimental observations  (3):  (a)  The  tolerant  state was 
maintained through as many as two serial adoptive transfers performed over a period 
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1  Abbreviations used in this paper: BGG, bovine gamma globulin; CFA, Freund's complete 
adjuvant; D-GL, D-glutamic acid and  n-lysine; KLH,  keyhole  limpet hemocyanin;  OVA, 
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1446  THE  JOURNAL OF  EXPERIMENTAL MEDICINE  •  VOLUME 139,  1974 TOSHIYUKI HAMAOKA AND  DAVID H.  KATZ  1447 
of time at least 24 days from the single exposure of primed cells to the tolerogen; 
(b)  The possibility that maintenance of tolerance through such serial transfers was 
due to inadvertent transfer of tolerogenic doses of DNP-D-GL was definitively ruled 
out; and (c) Finally, the possibility that tolerance by DNP-D-GL reflects blocking of 
surface receptor molecules on B  lymphocytes was argued against on the basis of the 
failure of enzymatic treatment with trypsin to reverse the tolerant state induced by 
in vitro exposure of cells to DNP-D-GL whereas, in contrast, trypsinization completely 
restored the immunocompetence of DNP-specific cells rendered unresponsive by ex- 
posure to DNP-ovalbumin in vitro. 
The present studies were undertaken  to further  explore the cellular events 
involved in specific inactivation by DNP-D-GL. The  intriguing paradox with 
this molecule is that it induces tolerance extremely rapidly following exposure 
of B  cells to it under normal conditions, and yet in  the presence of a  strong 
appropriately timed T-cell influence,  such as that provided by the allogeneic 
effect,  the molecule can  transmit  a  positive immunogenic  signal  (1,  4,  7-9). 
This provides, therefore, another method by which to test the relative perma- 
nence of B-cell inactivation by DNP-D-GL. An additional question of critical 
importance concerns the failure, as mentioned above, of trypsin to reverse the 
tolerance induced by DNP-D-GL  (3). To what extent does this  failure reflect 
the  fact  that  n-rotatory amino  acid  copolymers are  themselves  resistant  to 
digestion by mammalian enzymes? In the experiments herein, we present data 
bearing on  these  questions  and  additional parameters  of tolerance induction 
by DNP-D-GL. The evidence obtained in these studies reinforces the concept 
of central tolerance in B  cells induced by DNP-D-GL as reflecting sub- or in- 
tracellular inhibitory events. 
Materials and Methods 
Proteins  and Hapten-Carrier  Conjugates.--The  copolymers  of D-GL and L-glutamic  acid 
and L-lysine (L-GL) were obtained from Pilot Chemicals,  Inc., Watertown, Mass. Both iso- 
mers had an average mol wt of 50,000 and a ratio of G :L of 60:40. Keyhole limpet hemocyanin 
(KLH) was purchased from  Pacific Bio-Marine Supply Co., Venice, Calif.  Hen ovalbumin 
(OVA) 5x recrystallized and bovine gamma globulin (BGG) were obtained from Pentex Bio- 
chemicals, Kankakee, Ill. The following DNP conjugates were prepared as previously  described 
(10, 11): DNPn-KLH, DNP14-KLH,  and DNP20-L-GL. The  preparation of  DNP37-D-GL 
has been described in detail elsewhere (1). Subscripts refer to the average number of moles of 
DNP per mole of carrier for L-GL and D-GL and to the number of moles of DNP per 100,000 
tool wt units for KLH. 
Animals.--Mice  of  the  inbred  lines  BALB/c,  A/J,  and  (BALB/c)< A/J)F1  hybrids 
(CAF1) were obtained from Jackson Laboratories, Bar Harbor, Maine. All mice were immu- 
nized or used as recipients at 8-12 wk of age. 
Immunizations  and Adoptive Cell Transfers.--Mice used as donors of DNP-primed spleen 
cells were immunized by intraperitoneal injection of 100 #g of DNP-KLH emulsified in com- 
plete Freund's adjuvant (CFA). At various times after priming (usually 3-5 mo) suspensions 
in Eagle's minimum essential medium  (MEM) were prepared and washed. Depending on the 
nature of the experiment these cells were either subjected to some in vitro manipulation or 
transferred (see Results). Cells were transferred intravenously to syngeneic, irradiated (500- 1448  TOLERANCE IN  B  LYMPHOCYTES. II 
600 R) recipients. Secondary challenge was in all cases administered intraperitoneally with the 
DNP-KLH in saline. Recipient mice were bled from the retroorbital plexus 7 days after sec- 
ondary challenge and serum anti-DNP antibody levels were determined as described below. 
In Vitro Incubation Procedures.--In  experiments involving exposure of primed cells to toler- 
ogenic molecules in vitro, the following  conditions were used: for short term cultures (1-4 h), 
cells were incubated in closed plastic 50 ml culture tubes at a cell density of 20 X  106 cells/ml 
in MEM supplemented with 10% fetal calf serum. The cell suspensions were gently agitated 
every 15-20 min during incubation. For longer culture periods (2-4 days), cells were cultured 
in petri dishes under Mishell-Dutton conditions at a cell density of 30 X  106 cells/ml. In all 
cases, cells were thoroughly washed at termination of culture and viabilities determined by 
trypan blue exclusion. 
Treatment of Cells with Trypsin.--Enzymatic treatment of cells with trypsin was performed 
as follows: 30 X  106 cells were incubated for 20 min at 37°C in 1 ml of a freshly prepared 
solution  containing 150/zg/ml trypsin and  10 #g/ml DNAase  (Worthington  Biochemical 
Corp., Freehold, N. J.)  in MEM.  After trypsinization,  the cells were washed three times in 
MEM. 
Measurement of A nti-DNP A ntibodies.--Serum  anti-DNP antibody levels were determined 
by a modified Farr technique  (12, 13)  using [3H]DNP-e-amino-N-caproic acid  (10). Using 
standard curves constructed  for individual mouse strains in a manner identical to that de- 
scribed previously for inbred  guinea pigs  (10), percentage  of binding was converted into 
amount of anti-DNP antibody in micrograms per milliliter of serum. 
Statistical Analysis.--Serum antibody levels were logarithmically transformed and means 
and standard errors calculated. Group comparisons were made employing Student's t test. 
In those mice in which no specific antigen binding could be detected in the serum, a value of 
0.10/zg/ml was arbitrarily assigned to allow logarithmic transformation  of the data. 
RESULTS 
Capacity  of the Allogeneic Effect to  Alter or Reverse DNP-Specific  Tolerance 
Induced  by DNP-D-GL.--The  allogeneic effect has been shown to be a  potent 
T-cell stimulus capable of influencing  antigen-induced  activation of B  lympho- 
cytes  (4,  7,  14). Indeed the original observation that this phenomenon could 
convert a  normally strong  tolerogenic molecule such  as  DNP-D-GL into an 
immunogenic signal  (1)  provided the  strongest early evidence that  the  allo- 
geneic  T  cells  were  reacting  directly  with  DNP-specific  B  lymphocytes,  a 
point which has since been directly substantiated (7,  15,  16).  Moreover,  Os- 
borne and Katz have recently shown that an appropriately timed allogeneic 
effect can provide the necessary helper influence for generating primary anti- 
body responses of the IgG class to DNP-D-GL (9). 
The  observations mentioned above  provide  a  starting  point  to  question 
certain parameters of B-cell inactivation by DNP-D-GL. The most important 
of these concerns the degree of reversibility of such a  tolerant state inasmuch 
as this feature offers an indirect view into possible mechanisms involved. The 
following series of experiments were designed to probe the capacity of the allo- 
geneic effect, a  source of strong T-cell action, to alter the responsiveness of B 
cells subjected to various tolerance-inducing  regimens. 
When DNP-specific  tolerance is induced by incubation of DNP-KLH-primed cells in vitro 
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with DNP-KLH were incubated in culture tubes with either DNP-D-GL (2 #g/106 cells)  or 
saline. The cells were incubated at a cell density of 20 X  106 eells/ml at either 37°C or 4°C for 
1 h. Afterwards, the various aliquots of cells were washed three times with MEM and then 
counted. Equal numbers (20 X  106) of viable (trypan blue exclusion) saline-control cells and 
cells incubated with DNP-D-GL were transferred  intravenously to respective groups of X- 
irradiated  (550  R),  syngeneic CAFI mice.  Certain  groups  received an  additional  transfer, 
immediately after the first, of parental  BALB/c spleen cells (2 X  106 cells/recipient) while 
the remaining groups received no allogeneic ceils. Immediately thereafter, animals were either 
challenged with 10 #g of DNP-KLH intraperitoneally or not and then bled 7 days later. The 
1 : 10 ratio of allogeneic to primed cells employed is based on our previously reported observa- 
tion on optimal parameters for the phenomenon in mice (15). 
The far left panel  of Fig.  1 summarizes  schematically the protocol for these 
two  experiments.  The  left  and  right  data  panels  depict  the  results  obtained 
with  cells incubated  at  4°C and  37°C,  respectively. Essentially no substantial 
differences attributable  to  temperature  of incubation  were  observed.  In  both 
experiments  when  no  additional  allogeneic  cells  were  transferred,  very  good 
adoptive  secondary  anti-DNP  antibody  responses  were obtained  with  control 
cells incubated  with saline provided secondary  challenge with DNP-KLH  was 
carried  out.  Cells  incubated  with  DNP-D-GL  manifested  poor  responses  to 
DNP-KLH  challenge that  were diminished  by more  than  95 %  irrespective of 
the  temperature  of  incubation.  When  additional  allogeneic  cells  were  trans- 
ferred,  the  secondary  response  of control  saline-treated  cells was  enhanced  in 
Fro.  1.  Induction  of DNP-specific tolerance by incubation  of DNP-KLH-primed cells 
in vitro with DNP-D-GL before adoptive transfer. The protocol is depicted schematically on 
left of figure.  Two experiments are shown. In one the temperature of in vitro incubation of 
cells with either saline or DNP-D-GL was 4°C while in the other it was 37°C as indicated. 
Each group consists of five mice. Relevant statistical comparisons of secondary responses  to 
DNP-KLH challenge yielded the following P values: (a) cells incubated with DNP-1)-GL com- 
pared with saline-treated cells, 0.001  >  P  at both 4°C and 37°C and when transferred either 
with or without allogeneie cells; (b) cells incubated with DNP-D-GL and transferred together 
with allogeneic ceils as compared to DNP-D-GL-treated cells transferred without allogeneic 
cells, 0.05  >  P  >  0.025 at 4°C and 0.01  >  P  >  0.005 at 37°C. 1450  TOLERANCE IN  B  LYMPHOCYTES. II 
one experiment (right panel, 37°C incubation) but not in the other (left panel, 
4°C). The responses to DNP-KLH obtained with cells incubated with DNP- 
9-GL were increased as a  result of allogeneic cell transfer in both experiments. 
Whereas these increases are clearly statistically significant when compared to 
responses of cells exposed in vitro to DNP-D-GL and transferred without allo- 
geneic cells, it should be noted that the secondary responses in the presence of 
allogeneic cells were  still diminished by more  than  92 %  as  compared to  the 
responses of respective saline control cells in the presence of allogeneic cells. 
Nevertheless, the fact that a  significant increase in response could be obtained 
as a  result of allogeneic cell transfer indicates the presence of a  subpopulation 
of DNP-specific B cells capable of being triggered by a sufficient T-cell stimulus 
even after exposure to the tolerogenic signal. 
When DNP-specifie tolerance is induced  by exposure  of DNP-KLH-primed cells to DNP-D- 
GL in vivo in adoptive recipients:  This experiment utilized the system that we previously de- 
scribed for induction  of tolerance in DNP-primed cells in an adoptive transfer system by treat- 
ing recipients in vivo with appropriate doses of DNP-D-GL (3). The protocol is schematically 
depicted in the left panel of Fig. 2. Spleen  cells from CAFx donor mice primed 3 mo earlier 
with DNP-KLH were transferred  intravenously  to irradiated  (600 R), syngeneic recipients 
(50 X  106 cells/mouse) who were immediately thereafter treated with either saline or 500 #g 
of DNP-D-GL in saline intraperitoneally.  3 days later all mice were secondarily challenged 
with 10/~g of DNP-KLH i.p. 7 days after challenge these two groups were bled  and then 
sacrificed. Serum anti-DNP antibody levels reflected excellent responses in saline control re- 
cipients  (4,327 #g/ml average) and virtually no response in the  DNP-n-GL-treated  group 
(0.16 ~g/ml). Their respective spleen cells were pooled, washed, and transferred intravenously 
to  new, irradiated  CAF1 recipients  (50)<  10 ~ cells/mouse) either  together with unprimed 
parental  A/J spleen cells (5 X  106 cells/recipient) or without allogeneic cells. All mice were 
then immediately challenged with 10 #g of DNP-KLH intraperitoneally,  and bled 7 days 
later. 
Fro. 2.  Induction of DNP-specific tolerance by exposure of DNP-KLH-primed  cells to 
DNP-D-GL in vivo in adoptive recipients. The protocol is depicted schematically on left of 
figure. Each  group consists of six mice. Relevant statistical  comparisons of antibody re- 
sponses yielded the following  P values: (a) cells exposed to DNP-D-GL compared with saline- 
control cells, 0.001 >  P when transferred either with or without allogeneic cells; (b) cells ex- 
posed to DNP-D-GL and transferred together with allogeneic  cells as compared to DNP-D-GL- 
treated  cells transferred  without allogeneic cells -- 0.10 >  P  >  0.05. TOSHIYUKI HAMAOKA AND DAVID H.  KATZ  1451 
As shown in the right panel of Fig. 2, very good anti-DNP responses were 
elicited in the second adoptive recipients of primed cells exposed only to saline 
in the initial recipients, and these responses were not significantly affected by 
allogeneic cell transfer.  In  contrast,  cells exposed to DNP-D-GL in  the first 
recipients developed markedly diminished responses, lower by more than 90 % 
of controls, irrespective of whether or not allogeneic cells were included in the 
second transfer. 
When DNP-specific  tolerance is induced by in vitro exposure to DNP-D-GL of 
DN  P-KLH-primed spleen cells  from donors subjected to the allogeneic e~ect:--The 
preceding experiments failed to demonstrate any striking capacity of the allo- 
geneic effect to reverse tolerance induction by DNP-D-GL. It has been amply 
documented,  however,  that  timing  of  optimal  allogeneic  cell  interaction  to 
antigen encounter by B cells is critical for development of enhancing effects in 
this system (7, 8, 14, 17). It is possible that the preceding experiments did not 
allow sufficient time for generation of effective allogeneic cell interactions prior 
to the tolerogenic signal  from DNP-D-GL. The following experiment was de- 
signed to circumvent this possible explanation by inducing the allogeneic ef- 
fect in  the donors of DNP-KLH-primed cells before their subsequent in vitro 
exposure to DNP-D-GL. 
As depicted in Fig. 3, CAF~ mice  primed 3 mo earlier with DNP-KLH were injected in- 
travenously with parental BALB/c spleen cells (25 X l0 s cells/mouse). 2 days later, these 
mice and a group of comparably primed CAF1 donors that had not received allogeneic cells 
were sacrificed  and their spleens removed.  The pooled spleen cells from each donor group were 
then incubated in vitro for 1 h at 37°C with either saline or DNP-D-GL (3 #g/106 cells) as in 
the earlier experiment (Fig. 1). Afterwards, equal numbers of viable cells from the various 
aliquots were transferred intravenously to irradiated  (500 R)  CAF1 recipients (20 X 106 
cells/mouse) which were then either not challenged or secondarily  challenged  with 100 #g of 
DNP-KLH. 
Recipients of primed cells from donors not given allogeneic cells that were 
not exposed to DNP-D-GL in vitro developed high secondary anti-DNP anti- 
body responses to challenge with DNP-KLH (Fig. 3). Exposure of such cells 
to DNP-D-GL in vitro diminished the secondary response by 92 %  (the lower 
degree  of  tolerance  as  compared  with  the  preceding  experiments  probably 
reflects the log higher challenging dose of DNP-KLH). In the case of primed 
cells obtained from donor mice that had received allogeneic cells 2 days before 
sacrifice, several points are noteworthy: first, the secondary responses to DNP- 
KLH of saline-treated control cells from such donors were significantly lower 
(around 65 %)  than the responses obtained with donor cells not subjected to 
allogeneic cells in situ. The possibility that this result is merely a reflection of 
inherent qualitative differences in the donor cell pools unrelated to allogeneic 
cell transfer may be immediately dismissed since (a) differences of this magni- 
tude are not common, in our experience, when cell pools are prepared on the 
same day from 8-10 mice per donor pool group when all donors were primed 
at the same time and housed together, and (b)  this result has been observed 1452  TOLERANCE  IN B  LYMPHOCYTES.  II 
FIG. 3.  Induction of DNP-specific tolerance by in vitro exposure to DNP-D-GL of DNP- 
KLH-primed cells from donor mice subjected to an allogeneic effect. The protocol is schemati- 
cally depicted  on left of fgure. Each group consists of five mice. Relevant  statistical  com- 
parisons of responses yielded the following P values: (a) Cells incubated with DNP-D-GL com- 
pared with saline-treated  cells in response to secondary challenge with DNP-KLH-0.001  >  P 
when primed cells came from otherwise untreated  donors; 0.005 >  P  >  0.001 when primed 
cells came from donors treated with allogeneic cells; (b) cells from untreated donors compared 
to cells from donors treated  with  allogeneic cells-- (1)  in absence of secondary challenge, 
0.001 >  P  when cells exposed to DNP4)-GL in vitro; 0.30 >  _P >  0.20 when cells treated 
with saline; (2) in response to secondary challenge, 0.90 >  P  >  0.80 when cells exposed to 
DNP-D-GL in vitro;  0.01 >  P  >  0.005 when cells treated  with saline. 
by us in several experiments of this type. Second, despite the significantly sup- 
pressed responses in the aforementioned saline-control cells,  the magnitude  of 
responses manifested by the same donor cells that had been exposed to DNP- 
D-GL in vitro was disproportionately high in comparison to that of the saline- 
treated  cells,  and  essentially  equal  to  that  displayed by  DNP-D-GL-treated 
cells from the donor mice not given allogeneic  cells.  Finally,  the DNP-D-GL- 
treated cells from donors that had received allogeneic cells produced low level, 
but  nevertheless  highly  statistically  significant,  anti-DNP  antibodies  in  the 
absence of any secondary challenge with DNP-KLH. 
Taken  collectively, the latter  observations may indicate  that the allogeneic 
cell transfer to primed donor mice may, indeed,  have influenced the degree of 
tolerance  induction resulting from subsequent  in vitro DNP-D-GL treatment. 
Thus,  these  results  may reflect an  enhancing  influence  of the  allogeneic  cells 
on certain DNP-specific B  cells binding DNP-D-GL in the face of a  concomi- 
tant  suppressive  influence  exerted  by  the  allogeneic  effect  on  other  DNP- 
specific B cells and/or on KLH-specific helper T  cells. Alternatively, the dimin- 
ished  responses  of  the  saline-treated  cells  may  reflect  suppressive  allogeneic 
effects  on only helper  T  cells  in which  case  the  net  effect on the  responses of 
DNP-D-GL-treated cells might be nil. We are inclined to favor the former ex- 
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body production in the absence of any secondary challenge observed in recipi- 
ents of DNP-D-GL-treated cells from donors that had received allogeneic cells. 
Capacity  of Enzymatic  Treatment  of Cells with  Trypsin  to  Alter or Reverse 
DNP-Specific Tolerance Induced by DNP-D-GL.--In  our previous studies with 
this system in mice (3), we had been able to render DNP-KLH-primed spleen 
cells relatively unresponsive by exposing them for appropriate lengths of time 
in vitro to either DNP-D-GL or a DNP conjugate of an unrelated carrier  pro- 
tein such as OVA.  Thus, cells exposed to these reagents developed markedly 
diminished adoptive secondary anti-DNP antibody responses when transferred 
to irradiated recipients and challenged with DNP-KLH. However, a difference 
in the unresponsive states caused by DNP-D-GL as opposed to DNP-OVA was 
shown in that gentle enzymatic treatment of such cells with trypsin completely 
reversed the unresponsiveness in the case of cells exposed to DNP-OVA,  but 
not in the case of cells exposed to DNP-D-GL. This observation formed a strong 
basis for our contention that tolerance induction by DNP-D-GL involves com- 
plex,  irrevocable  intra-  or  subcellular  events  following a  tolerogenic  signal 
probably generated at the surface membranes of such cells consequent to spe- 
cific binding of the molecule (3). 
The possible flaw in the above reasoning lies in the fact that our own concept 
of how trypsin might have worked in reversing DNP-OVA-induced unrespon- 
siveness was by stripping the cell membrane of its specific receptors and  any 
DNP-OVA attached to them. This in turn would result in resynthesis of surface 
receptors  and  the  intact capability of such  cells  to  respond.  The  failure of 
trypsinization to  reverse  the  tolerant state  induced by DNP-D-GL  was  ex- 
plained in the context of an irreversible intracellular inactivation process not 
subject  to  manipulations at  the  cell  surface.  Another  possible  explanation, 
with altogether different implications for mechanisms of tolerance in this system 
is that being a nonmetabolizable molecule, DNP-D-GL is not itself subject to 
enzymatic degradation and may thereby prevent accessibility of other surface 
membrane sites to the enzyme. If this were the case, then the index of irreversi- 
bility by  trypsin  as  a  reflection of intracellular mechanisms of inactivation 
may be quite invalid. We have therefore performed a series  of experiments to 
put these questions to direct analysis. 
Failure to reverse tolerance induced  in vivo with DNP-D-GL or DNP-L-GL by 
trypsinization of cells before adoptive transfer:  The protocol of this experiment 
is schematically depicted in the left panel of Fig. 4. Briefly, spleen cells from 
CAF1 mice primed 3 mo earlier with DNP-KLH were transferred intravenously 
to irradiated (550 R) syngeneic recipients (50 X  l0 s cells/mouse). Immediately 
thereafter,  groups  of recipients were injected with either saline, DNP-D-GL 
(500 ~g), or DNP-L-GL (500/~g)  intraperitoneally. 3 days later, all mice were 
challenged with 100/zg of DNP-KLH and then bled 7 days later. The anti- 
DNP antibody responses of these groups of recipients are summarized in the 
top right panel of Fig. 4 where it is shown that recipients treated with either 1454  TOLERANCE  IN  B  LYMPHOCYTES.  II 
FIG. 4.  Failure  to reverse tolerance induced in vivo with DNP-D-GL or DNP-L-GL by 
trypsinization  of cells before adoptive transfer. The protocol is schematically depicted on the 
left. Each group consists of 10 mice in the top panel, five mice in the bottom panel. Relevant 
statistical  comparisons of responses yielded the following P values: (a) top panel, comparison 
of saline-treated  controls with DNP-I)-GL-treated  cells, and DNP-L-GL treated  cells yielded 
0.001 >  P in both cases; (b) bottom panel--(/) saline-treated control cells compared to DNP- 
I)-GL or DNP-L-GL-treated  cells, 0.001 >  P irrespective of whether or not cells were treated 
with  trypsin;  (2) nontrypsinized  DNP-I)-GL or DNP-L-GL-treated  cels compared  to their 
respective  trypsinized  counterparts,  0.10 >  _P >  0.05 in both cases. 
DNP-D-GL  or  DNP-L-GL  were  significantly  unresponsive  as  compared  to 
saline  controls  (98%  and  92%  diminution  by  DNP-D-GL  and  DNP-L-GL, 
respectively). 
The  spleen  cells  from  these  respective  groups  of mice  were  obtained  and 
then washed three times with MEM. Each pool was divided into two samples, 
one of which was left untreated  while the second was treated  with trypsin as 
outlined  in  Materials  and  Methods.  Groups  of irradiated  (550  R),  syngeneic 
recipient mice were injected intravenously (50  >(  106 cells/mouse)  with either 
untreated  or  trypsinized  cells  from  the  respective  donor  mouse  groups.  All 
mice were challenged with  100/zg of DNP-KLH intraperitoneally immediately 
after cell transfer and then bled 7 days later. As shown in the lower right panel 
of Fig. 4,  cells exposed to saline  in  the  initial  recipients  developed very good 
adoptive  anti-DNP  antibody responses  in  the  final  recipients;  trypsinization 
slightly,  but  not  significantly,  improved  these  responses.  In  contrast,  cells 
exposed  to  either  DNP-D-GL  or  I)NP-L-GL  failed  to  respond  in  the  final 
recipients and this inability to respond was not appreciably reversed in either 
case by trypsinization. 
Failure  to  reverse tolerance induced  by DNP-•-GL  and  reversal of  tolerance 
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FIG. 5.  Failure to reverse tolerance induced by DNP-D-GL and reversal of tolerance in- 
duced by DNP-L-GL in vitro by trypsinization of cells before adoptive transfer. The protocol 
is schematically depicted  on the left.  Each group consists of five mice. Relevant statistical 
comparisons of responses yielded the following _P values: nontrypsinized  vs. trypsinized  saline 
control  cells, 0.20 >  P  >  0.10;  nontrypsinized  vs.  trypsinized  DNP-~-GL-treated  cells, 
0.90 >  P  >  0.80;  nontrypsinized  vs.  trypsinized  DNP-L-GL-treated  cells,  0.05 >  _P > 
0.025; nontrypsinized  saline controls  vs. nontrypsinized  DNP-D-GL and DNP-L-GL-treated 
cells, 0.01 >  P  >  0.005 in both cases;  trypsinized  saline  controls  vs. trypsinized  DNP-D- 
GL-treated cells and DNP-L-GL-treated cells, 0.01  >  P  and 0.60 >  P  :> 0.50, respectively. 
In  the first experiment  of this  type,  depicted  in  Fig.  5,  spleen  cells from A/J 
donor  mice  primed  51/~ mo  earlier  with  DNP-KLH  were  incubated  at  37°C 
in Mishell-Dutton  conditions  at a  density of 30  X  106 cells/ml with 3/zg/106 
cells of either DNP-D-GL or DNP-L-GL, or saline alone. After 48 h, the respec- 
tive  cell  groups  were  harvested  from  the  dishes  and  washed  three  times  in 
MEM. Each pool was divided into two samples, one of which was left untreated 
while  the  second  was  trypsinized.  The  respective  cell  pools  were  then  trans- 
ferred to irradiated,  syngeneic recipients  (15  X  106 cells/recipient)  which were 
challenged with  100 Izg of DNP-KLH  and then bled 7 days later. 
As shown in Fig. 5, recipients  of cells incubated  with saline developed good 
adoptive  secondary  responses  to DNP-KLH  and  trypsinization  of such  cells 
resulted  in  a  substantial  increase  in  the  magnitude  of  these  responses.  The 
latter  finding  has been  consistent  in many such  experiments  and  will  be dis- 
cussed at greater length  below. Recipients  of cells incubated  with DNP-D-GL 
were significantly diminished  in  their secondary responses  (86%  as compared 
with controls)  and,  moreover, treatment  with  trypsin  did not abolish the un- 
responsive  state.  In striking  contrast  are the results  obtained  in recipients  of 
cells incubated  with  DNP-L-GL.  If such  cells were  transferred  without  tryp- 
sinization,  a  very  significant  level  of suppression  (88 %)  comparable  to  that 
induced by DNP-D-GL occurred.  Treatment  of such cells with trypsin,  on the 1456  TOLERANCE  IN B  LYMPHOCYTES.  II 
other hand, restored the adoptive secondary anti-DNP response to essentially 
normal levels. 
The capacity of trypsinization  to reverse tolerance induced  by DNP-L-GL 
exposure  in  vitro but  not  in  the  previous in  vivo experiment  (Fig.  4)  may 
reflect a kinetic difference in efficiency of tolerance induction with this molecule 
in the contrasting conditions. Another experiment was performed in which the 
time of in vitro exposure to DNP-L-GL was lengthened from 2 to 4 days (Fig. 
6). The experimental conditions were essentially identical to those of the pre- 
ceding experiment  (Fig.  5)  except that  CAF1 donor  and recipient mice were 
employed and cells were exposed to either saline alone or DNP-L-GL (3 ~g/106 
FIG. 6.  Reversal of tolerance induced by DNP-L-GL in vitro by trypsinization of cells 
before adoptive transfer. The protocol is schematically depicted on the left. Each group con- 
sists of five-six mice. Relevant statistical comparisons of responses yielded the following _P 
values: (a) nontrypsinized saline controls vs. nontrypsinized DNP-L-GL-treated cells, 0.025 > 
P  >  0.01; (b)  trypsinized saline controls vs.  trypsinized DNP-L-GL-treated cells, 0.50 > 
P  >  0.40; (c)  nontrypsinized DNP-L-GL-treated cells vs.  either  trypsinized DNP-L-GL- 
treated cells or saline controls (trypsinized or not), 0.001 >  P in all cases. 
cells) for 4 days. The results summarized in Fig. 6 demonstrate again the un- 
responsive state as compared to controls induced by exposure of cells to DNP- 
L-GL in vitro and the complete reversal of the unresponsiveness by treatment 
of such cells with trypsin before adoptive transfer. 
Reversal of tolerance induced  by DNP-•-GL  in vitro at 4°C by trypsinization 
of cells before adoptive transfer:  The  question  of  whether  or not  conditions 
could be found whereby trypsin could be employed to reverse (or rather pre- 
vent)  the  tolerance-inducing  sequence  of cellular  events  was  approached by 
taking  advantage  of the  fact that  tolerance  induction  readily  occurs in  this 
system by in  vitro incubation  of primed  cells  with  DNP-D-GL even  at  low 
temperatures  (5,  and  experiments  presented  here).  We  reasoned,  therefore, 
that  perhaps  at  low  temperature  the  transduction  of any  tolerogenic  signal 
might  be  sufficiently  delayed  so  that  reversal  by  trypsinization  would  be 
feasible if the  cells  were  subjected  to  this  enzymatic treatment  right  away. 
The following experiment demonstrates that, indeed,  this is true (Fig. 7). TOSHIYUKI HAMAOKA AND  DAVID H.  KATZ  1457 
FIG. 7.  Reversal of tolerance induced by DNP-D-GL in vitro at 4°C by trypsinization of 
cells before adoptive transfer. The protocol is depicted schematically on the left. Each group 
consists of five-six mice. Relevant statistical comparisons of responses yielded the following P 
values: (a) nontrypsinized saline controls vs. nontrypsinized DNP-D-GL-treated cells, 0.005 > 
P  >  0.001 and 0.001 >  P at 4°C and 37°C incubation temperatures, respectively; (b) trypsi- 
nized saline controls vs. trypsinized DNP-D-GL-treated cells, 0.30 >  P  >  0.20 and 0.005 > 
P  >  0.001 at 4°C and 37°C incubation temperatures, respectively. 
Spleen cells from CAF1 donor mice primed 3 mo earlier with DNP-KLH were incubated 
in culture tubes with either DNP-D-GL (3/zg/106 cells) or saline. The cells were incubated at 
either 4°C or 37°C for 2 h. Afterwards, the respective cell groups were washed three times in 
MEM and then each divided into two samples,  one of which was left untreated while the 
second was trypsinized as before. The respective cell pools were then transferred intravenously 
to irradiated (550 R) syngeneic recipients (20 X  106 cells/recipient) which were challenged 
with 100 #g of DNP-KLH and then bled 7 days later. 
As  shown  in  Fig.  7,  recipients  of  saline  control  cells  incubated  at  either 
temperature  developed  very  good  adoptive  secondary  anti-DNP  responses 
and, again these responses were improved by treatment  with trypsin. Recipi- 
ents  of  cells exposed  to  DNP-D-GL  but  not  trypsinized before  transfer  dis- 
played markedly depressed responses irrespective of the temperature  of incu- 
bation  (91%  and  95 %  diminished at 4°C  and 37°C,  respectively). However, 
treatment  of these  cells with  trypsin  before  transfer  had  a  significant effect 
upon  their subsequent  capacity to respond which  was  determined to a  great 
extent upon the temperature used for incubation with DNP-D-GL. Thus, cells 
exposed to DNP-D-GL at 4°C developed secondary responses after trypsiniza- 
tion  that  were  not  statistically significantly  different  from  those  of  saline 
control cells also treated with trypsin (0.30  >  P  >  0.20). Indeed, the magni- 
tude of the responses in this group was even greater than  that obtained with 
saline  control  cells not  subjected  to  trypsin  treatment.  In  the  case  of  cells 
incubated  with  DNP-D-GL  at  37°C,  trypsinization  markedly  improved  the 
ultimate  response  by  comparison  with  those  of  cells exposed  to  DNP-D-GL 
but not  trypsinized (10-fold), but  did not  abolish the statistically significant 
difference with  respect  to  responses  of saline control  cells incubated  at  that 
temperature and then treated with trypsin (0.005  >  P  >  0.001). 1458  TOLERANCE  IN  B  LYMPHOCYTES.  II 
DISCUSSION 
In the studies presented here,  we have extended our previous observations 
on the state of DNP-specific tolerance induced by the DNP derivative of the 
copolymer of D-glutamic acid and D-lysine. In so doing,  we have deliberately 
focused on  the  question  of reversibility of inactivation  at  the  B-cell level  to 
develop a  more cogent understanding  of the cellular events that occur subse- 
quent  to  binding  of the  tolerogenic moiety.  The  capacity of a  strong T-cell 
stimulus, such as that provided by the allogeneic effect, and of gentle enzymatic 
treatment  with  trypsin  to alter,  prevent or reverse the  tolerance induced  by 
DNP-~-GL have been tested in a variety of ways. 
As  mentioned  in  the  Introduction,  DNP-D-GL  represents  a  rather  intriguing 
molecule in that under normal conditions  it is highly tolerogenic  for DNP-specific B 
cells. This is true over a very wide dose range both in vivo and in vitro (1-6) ; in con- 
trast  to  other  antigenic  moieties considered  to  be relatively  thymus-independent, 
DNP-D-GL does not appear to be capable of eliciting antibody responses even at very 
low doses in mice either in vivo (9) or in vitro (5).2 However, in the milieu of a very 
strong T-cell stimulus, DNP-D-GL has been shown to transmit immunogenic signals 
to specific B lymphocytes (1, 4, 7-9). Thus, DNP-primed lymphocytes will develop 
secondary anti-DNP antibody responses  to challenge  with DNP-D-GL provided an 
appropriately timed transient graft-vs.-host reaction (allogeneic  effect) has been in- 
duced (1, 4, 7, 8). Unprimed DNP-specific lymphocytes can also be induced to primary 
anti-DNP antibody production, and of the IgG class, by DNP-D-GL in the presence 
of an allogeneic effect (9). Indeed, it is particularly interesting that DNP-D-GL works 
in an allogeneic effect on unprimed B cells whereas normal immunogenic conjugates 
such as DNP-KLH fail to behave in the same fashion  (9). 
In the present experiments, we have attempted to manipulate the system of 
tolerance induction  in  a  variety of ways to determine  if the allogeneic effect 
could  alter  the  tolerant  state.  It should  be stressed that  the  main  emphasis 
here was to attempt to alter cellular events presumably already set in motion 
(or perhaps completed) by reaction with the tolerogenic molecule, and proto- 
cols were designed accordingly.  It is already sufficiently clear on  the basis of 
ample direct evidence, mentioned above, that the allogeneic effect can prevent 
a  tolerogenic  signal  from ensuing,  indeed  converting the  signal  to an  immu- 
nogenic  one.  In  the  guinea  pig  system,  we  were  unsuccessful  in  rescuing  B 
lymphocytes from a state of unresponsiveness induced by DNP-D-GL by sub- 
jecting  such  animals  subsequently  to  an  allogeneic  effect  (1).  The  present 
experiments confirm this general conclusion in that cells previously exposed to 
DNP-D-GL, and rendered  markedly unresponsive by such  exposure either in 
vitro (Fig.  1)  or in vivo (Fig.  2), failed to be appreciably reversed to a  state 
of responsiveness by subsequent exposure to an allogeneic effect. On the other 
hand, when allogeneic cell interactions were induced in vivo within the DNP- 
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primed donor lymphoid cell population before exposure of such cells to DNP- 
D-GL in vitro, then some degree of B-cell stimulation could be detected (Fig. 3). 
These observations point out once again the previously noted contrasting 
effects of the DNP-D-GL molecule on DNP-specific B lymphocytes depending 
on the existing conditions at the critical moment of receptor-substrate binding. 
In normal circumstances, binding of DNP-D-GL results in functional inactiva- 
tion of DNP-specific B  cells.  This tolerant state is induced extremely rapidly 
and is not reversible once it has occurred. In marked contrast, however, is the 
capacity of this very same molecule to serve as a potent stimulus for differen- 
tiation of DNP-specific precursor B cells to antibody-producing cells when the 
initial binding event takes place in a  milieu of strong T-cell activity such as 
that exerted by the allogeneic effect (1, 4,  7-9). In this respect, however, the 
critical moment of specific  binding of DNP-D-GL must occur during or after 
the generation of this T-cell activity; if the binding event precedes the devel- 
opment of T-cell participation, no stimulation will occur as a result of the very 
rapid kinetics of the tolerogenic events within the cell population exposed to 
this molecule. 
The series of experiments involving the effects of enzymatic treatment with 
trypsin were performed to clear up several uncertainties regarding the signifi- 
cance of our previous failure to reverse DNP-D-GL-induced B-cell tolerance 
by such treatment (3). In those studies, we observed that in vitro exposure of 
DNP-KLH-primed cells  to either DNP-D-GL  or to a  DNP  conjugate of an 
unrelated carrier protein such as OVA rendered such cells unresponsive upon 
subsequent adoptive transfer and challenge with DNP-KLH. However, tryp- 
sinization of cells before adoptive transfer reversed the tolerance in the case of 
cells incubated with DNP-OVA but not in the case of cells treated with DNP- 
o-GL (3).  This observation provided a  forceful argument in favor of the hy- 
pothesis that B-cell tolerance induced by DNP-D-GL represented an irreversible 
state of intracellular inactivation resulting from a tolerogenic signal generated 
at the cell  surface membrane. In addition, the fact that DNP-OVA-treated 
cells  were initially unresponsive but could be reversed by trypsinization ap- 
peared to point out at least a  second distinct type of tolerance mechanism in 
B  cells  whereby transient unresponsiveness occurred due to surface receptor 
"blockade" presumably resulting from the binding of specific determinants by 
B cells in the absence of a suitable T-cell influence. The latter issue is, indeed, 
an important one which is considered in greater depth in the accompanying 
manuscript (18). 
Our previous reasoning, therefore, was based essentially on the notion that 
trypsinization strips the cell surface membrane of its exocytic receptors and, 
of course,  any determinants bound to  those  receptors.  Provided no central 
inactivation process had occurred, such cells would be capable of resynthesizing 
their  surface receptors  and presumably of responding again  to  antigen.  By 
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reversed  by  trypsinization  might  be  considered  to  reflect  a  mechanism  of 
surface receptor blockade. Conversely, any state of unresponsiveness not sus- 
ceptible to reversal by trypsin might be considered to reflect a mechanism of 
intra- or subcellular inactivation. Such reasoning does not exclude the possi- 
bility  that  the  former mechanism  might  not  ultimately result in  the  latter 
events given sufficient time. 
An  objection to our previous interpretation,  which  we failed to  take  into 
account at that time, is the possibility that DNP-D-GL might virtually cover 
the surface of cells to which it becomes bound and, being itself resistant to the 
action of trypsin, prevent accessibility of other susceptible surface membrane 
components  to  the  enzyme. This possibility  has  been  pointed out  to  us  by 
many of our friends and colleagues and prompted us to explore this question 
in great depth. The results of the experiments reported herein demonstrate, we 
believe, that the failure of trypsin to reverse tolerance under certain circum- 
stances is,  indeed, a  reflection of a  state of irrevocable cellular refractoriness 
and not explained by inaccessibility of the surface membrane components to 
the enzyme. This conclusion derives from the observation that under appro- 
priate  conditions  of in  vitro  tolerance induction  by  DNP-D-GL,  enzymatic 
treatment  with  trypsin  can,  in  fact,  prevent  full  tolerance  from  becoming 
established (Fig. 7). Thus, when exposure of cells to DNP-D-GL for a relatively 
short time in vitro is carried out at low temperature (4°C),  the development 
of tolerance can be interceded by immediate trypsinization. Trypsin treatment 
also substantially improved the responsiveness of cells exposed to DNP-D-GL 
at 37°C but to a lesser extent than was observed with cells treated at 4°C. We 
interpret these data to indicate that:  (a)  the effect(s) of trypsin in reversing 
(or preventing)  tolerance at the cellular level does not depend necessarily on 
the susceptibility of the tolerogenic moiety to the action of the enzyme, and 
(b)  the generation of the tolerance-inducing signal involves metabolic cellular 
processes that can be delayed somewhat by low temperature leaving such cells 
relatively more susceptible to intercedent manipulations such as trypsinization. 
At first glance, the failure of trypsin treatment to reverse tolerance induced 
by DNP-L-GL in vivo appears to be contradicted by the rather ready reversal 
of tolerance induced by the same molecule when in vitro conditions are  em- 
ployed  (Figs.  5  and  6).  However,  the  efficiency, kinetics,  and  duration  of 
tolerance induction in vivo has always been of considerably greater magnitude 
than tolerance induced in vitro in our hands  (3). Moreover, data will  be pre- 
sented in the following paper which documents a  similar situation with toler- 
ance induced in vivo with immunogenic molecules such as DNP-OVA under 
proper conditions (18). Finally, it should be pointed out that the experiments 
presented  herein  are  representative of three-four experiments  of each  type, 
which all reproduce these basic observations quite consistently. 
It has also become clear that our other interpretation concerning reversibility of 
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were unresponsive as a result of surface receptor blockade but had not yet undergone 
irrevocable intracellular inactivation, is most likely incorrect. This is based on very 
recent observations of Ault and Unanue  8  which deomonstrate that DNP-KLH-primed 
B cells which bind metabolizable molecules such as DNP-OVA clear these molecules 
from their surface membranes quite rapidly and resynthesize their specific immuno- 
globulin  receptors within hours. Nonetheless, as shown by our earlier observations 
with DNP-OVA (3) and by the observations with DNP-L-GL in the present report, 
such treated  cells are functionally unresponsive unless  an additional manipulation, 
such as enzymatic treatment with trypsin, is performed. The fact that trypsin is so 
capable of reversing unresponsiveness  in  certain circumstances, even when there is 
no overt surface receptor blockade by antigen,  coupled  with the observations cited 
herein  on  the  significantly  increased  responsiveness  of control cells  to homologous 
antigen challenge  following trypsinization (Figs.  5 and 7) raises important questions 
concerning  the operational influence of trypsin on lymphocyte activation. 
In summary, then,  although  our previous reasoning on  the reversibility of 
B-cell  tolerance  by  enzymatic  treatment  with  trypsin  was  incorrect  in  the 
assumption  that  trypsin  was acting by clearing  off "blocked" receptors,  the 
conclusion  drawn  from this  reasoning,  however,  was nevertheless apparently 
correct.  Thus,  B-cell  tolerance appears  to  be distinguished  into  at  least  two 
categories based on  the  systems employed: the first category, exemplified by 
perhaps nonphysiological molecules such as DNP-D-GL, involves rapid irrever- 
sible tolerance most likely generated initially as a  cell surface signal but ulti- 
mately resulting in extremely rapid and irrevocable inactivation via events at 
the intra- or subcellular level. The second category, exemplified by physiological 
molecules and their analogues (such as DNP-OVA), involves cell surface bind- 
ing  and  subsequent  unresponsiveness,  but  the  state  is  clearly reversible by 
certain maneuvers at least for a  finite time, and may or may not either spon- 
taneously reverse itself or develop into irrevocable inactivation. It is with this 
second category, and the relationship of T-cell function  to it,  that the follow- 
ing paper will be concerned (18). 
SUMMARY 
The studies presented here have focused on the important question of rever- 
sibility of inactivation  of DNP-specific B  lymphocytes induced  by the DNP 
derivative  of  the  copolymer of D-glutamic  acid  and  D-lysine  (D-GL).  In  so 
doing, we have analyzed the capacity of a strong T-cell stimulus, such as that 
provided  by  the  allogeneic  effect,  and  of  gentle  enzymatic  treatment  with 
trypsin  to  alter,  prevent,  or  reverse  the  tolerance  induced  by  DNP-D-GL. 
Under  experimental  conditions  in  which  DNP-specific  B  lymphocytes  were 
exposed first to the tolerogenic molecule, and rendered markedly unresponsive 
by such  exposure either  in  vitro or in  vivo, subsequent  exposure to an  allo- 
3 K. Ault, and E. R. Unanue, 1974. Events following the binding of  antigen to lympho- 
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geneic effect failed to appreciably reverse or alter the tolerant state.  This con- 
trasts directly with the capacity of DNP-D-GL to serve as a stimulus for DNP- 
specific  B  lymphocytes when  the  critical  moment  of specific  binding  occurs 
subsequent  to  the  development  of  an  allogeneic  effect.  In  another  series  of 
experiments,  the  effects of enzymatic treatment  with  trypsin  on  the  tolerant 
B-cell population  were found to vary depending  on the stage  of tolerance  at 
which such treatment  was performed.  Thus,  when  exposure  of cells  to DNP- 
D-GL for  a  relatively  short  time  in  vitro  is  carried  out  at  low  temperature 
(4°C),  the development of tolerance can be interceded by immediate  trypsini- 
zation.  In  contrast,  cells  exposed  to  DNP-D-GL  for  longer  periods  of  time 
and/or  at 37°C were not reversed  to responsiveness  by trypsinization.  These 
data were interpreted  to indicate  that:  (a)  the effect(s)  of trypsin in reversing 
(or preventing)  tolerance  at  the  cellular  level does not depend necessarily on 
the  susceptibility  of the  tolerogenic moiety to the  action  of the  enzyme, and 
(b)  the  generation  of the tolerance-inducing signal  involves metabolic cellular 
processes that can be delayed somewhat by low temperature leaving such cells 
relatively  more  susceptible  to  intercedent  manipulations  such  as  trypsiniza- 
tion.  Taken  collectively,  therefore,  the  evidence  obtained  in  these  studies 
reinforces  the  concept of central  tolerance  in  B  cells  induced  by DNP-I)-GL 
as reflecting sub- or intracellular  inactivating events. 
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